S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3

Detalles Bibliográficos
Autores principales: Mohty, Mohamad, Tomasson, Michael H., Arnulf, Bertrand, Bahlis, Nizar J, Rodríguez-Otero, Paula, Martinez-Lopez, Joaquín, Touzeau, Cyrille, Quach, Hang, Depaus, Julien, Yokoyama, Hisayuki, Manier, Salomon, Raje, Noopur, Raab, Marc S., Searle, Emma, Leip, Eric, Sullivan, Sharon T., Czibere, Akos, Viqueira, Andrea, Lesokhin, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428276/
http://dx.doi.org/10.1097/01.HS9.0000967696.13096.54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428276/
http://dx.doi.org/10.1097/01.HS9.0000967696.13096.54

Ejemplares similares